Company Profile - Savara Inc
Introduction
Savara Inc (Savara), formerly Mast Therapeutics Inc, is a clinical-stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of PAP; and AeroVanc, an inhaled formulation of vancomycin for the treatment of CF. The company has subsidiaries in the US, and Denmark. Savara is headquartered in Austin, Texas, the US.
Company info
| Country (HQ): | United States |
| Sector: | Medical Equipment |
| Market Cap (US$ m): | 283 |
| Revenue (US$ m): |
Innovation ranking
197
Innovation score
Closest peers in the Medical Equipment sector
Innovation Ranking
Company
Headquarters
Sector
Medtronic Plc
Ireland
Medical Equipment
Boston Scientific Corp
United States
Medical Equipment
Savara Inc
United States
Medical Equipment
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release
